The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview
Authors
Keywords
-
Journal
Biomedicines
Volume 11, Issue 11, Pages 2985
Publisher
MDPI AG
Online
2023-11-07
DOI
10.3390/biomedicines11112985
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of prokineticin system in Crohn's disease pathophysiology and pain, and its modulation by alcohol abuse: A preclinical study
- (2023) Amodeo Giada et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods
- (2023) Zi-An Chen et al. Scientific Reports
- Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model
- (2023) Giulia Galimberti et al. Cells
- Prokineticin-Receptor Network: Mechanisms of Regulation
- (2022) Roberta Lattanzi et al. Life-Basel
- Inflammatory bowel disease and carcinogenesis
- (2022) Hiroko Nagao-Kitamoto et al. CANCER AND METASTASIS REVIEWS
- Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
- (2022) Daniela Maftei et al. Current Neuropharmacology
- Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
- (2022) Tania H. Bisgaard et al. Nature Reviews Gastroenterology & Hepatology
- Prokineticin 2 in cancer-related inflammation
- (2022) Roberta Lattanzi et al. CANCER LETTERS
- Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn′s Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition
- (2022) Giulia Rizzo et al. Cellular and Molecular Gastroenterology and Hepatology
- The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
- (2021) Roberta Lattanzi et al. Frontiers in Pharmacology
- The Antagonism of the Prokineticin System Counteracts Bortezomib Induced Side Effects: Focus on Mood Alterations
- (2021) Giada Amodeo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain
- (2021) Muhammad Nazirul Mubin Aziz et al. Nutrients
- Interplay between Prokineticins and Histone Demethylase KDM6A in a Murine Model of Bortezomib-Induced Neuropathy
- (2021) Laura Rullo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study
- (2021) Noriyuki Tagai et al. World Journal of Surgical Oncology
- Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
- (2021) Marianna Lucafò et al. Frontiers in Pharmacology
- Abnormal gut motility in inflammatory bowel disease: an update
- (2020) G. Bassotti et al. Techniques in Coloproctology
- Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis
- (2020) Xinxiu Li et al. Journal of Immunology Research
- Cytokines in inflammatory bowel diseases – Update 2020
- (2020) M. Leppkes et al. PHARMACOLOGICAL RESEARCH
- Prokineticin Receptor Inhibition With PC1 Protects Mouse Primary Sensory Neurons From Neurotoxic Effects of Chemotherapeutic Drugs in vitro
- (2020) Giorgia Moschetti et al. Frontiers in Immunology
- Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy
- (2019) Giorgia Moschetti et al. Journal of Neuroinflammation
- Resolution of ulcerative colitis
- (2019) Markus F. Neurath et al. Seminars in Immunopathology
- Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior
- (2019) Giorgia Moschetti et al. BRAIN BEHAVIOR AND IMMUNITY
- Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment
- (2019) Luísa Leite Barros et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1
- (2019) Daniela Maftei et al. NEUROSCIENCE
- Global burden of inflammatory bowel disease
- (2019) Vipul Jairath et al. Lancet Gastroenterology & Hepatology
- Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration
- (2018) Bjoern O. Schroeder et al. Cell Host & Microbe
- The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
- (2018) Lucia Negri et al. PHYSIOLOGICAL REVIEWS
- Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
- (2018) Yu Yoshida et al. Oncotarget
- Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis
- (2018) Manisha Bajpai et al. DIGESTIVE DISEASES AND SCIENCES
- Environmental triggers in IBD: a review of progress and evidence
- (2017) Ashwin N. Ananthakrishnan et al. Nature Reviews Gastroenterology & Hepatology
- The prokineticin system: an interface between neural inflammation and pain
- (2017) Silvia Franchi et al. NEUROLOGICAL SCIENCES
- Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system
- (2017) Manuela Zinni et al. PLoS One
- Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
- (2017) Felipe A. Pinho-Ribeiro et al. TRENDS IN IMMUNOLOGY
- IBS and IBD — separate entities or on a spectrum?
- (2016) Robin Spiller et al. Nature Reviews Gastroenterology & Hepatology
- Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes
- (2016) Mara Castelli et al. PLoS One
- How to predict clinical relapse in inflammatory bowel disease patients
- (2016) Elisa Liverani WORLD JOURNAL OF GASTROENTEROLOGY
- Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells
- (2015) LINAN REN et al. Molecular Medicine Reports
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice
- (2015) F. Guida et al. PHARMACOLOGICAL RESEARCH
- Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
- (2015) Hidetaka Kurebayashi et al. Oncotarget
- Prokineticin 2 Upregulation in the Peripheral Nervous System Has a Major Role in Triggering and Maintaining Neuropathic Pain in the Chronic Constriction Injury Model
- (2015) Roberta Lattanzi et al. Biomed Research International
- Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
- (2015) Dorothee Heck et al. Hormones & Cancer
- Prokineticin 1 Protein Expression is a Useful New Prognostic Factor for Human Sporadic Colorectal Cancer
- (2014) Toshiyuki Nakazawa et al. ANNALS OF SURGICAL ONCOLOGY
- Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
- (2014) D Maftei et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mild Moxibustion Decreases the Expression of Prokineticin 2 and Prokineticin Receptor 2 in the Colon and Spinal Cord of Rats with Irritable Bowel Syndrome
- (2014) Cili Zhou et al. Evidence-based Complementary and Alternative Medicine
- Inflammatory bowel disease: Pathogenesis
- (2014) Yi-Zhen Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Gastrointestinal motility disorders in inflammatory bowel diseases
- (2014) Gabrio Bassotti WORLD JOURNAL OF GASTROENTEROLOGY
- Innate and adaptive immunity in inflammatory bowel disease
- (2013) Alessandra Geremia et al. AUTOIMMUNITY REVIEWS
- Mechanisms of Bv8-induced biphasic hyperalgesia: Increased excitatory transmitter release and expression
- (2012) Milena De Felice et al. NEUROSCIENCE LETTERS
- Gastrointestinal infection as a trigger for inflammatory bowel disease
- (2011) Elizabeth A. Mann et al. CURRENT OPINION IN GASTROENTEROLOGY
- Intestinal Inflammation and Cancer
- (2011) Thomas A. Ullman et al. GASTROENTEROLOGY
- Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status
- (2011) Robert V. Bryant et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport
- (2011) Robert P. Watson et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Pain and inflammatory bowel disease
- (2009) Klaus Bielefeldt et al. INFLAMMATORY BOWEL DISEASES
- Enteric neuroglial apoptosis in inflammatory bowel diseases
- (2009) Gabrio Bassotti et al. Journal of Crohns & Colitis
- The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain
- (2009) E. Giannini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prokineticin Receptors in Cardiovascular Function: Foe or Friend?
- (2009) Canan G. Nebigil TRENDS IN CARDIOVASCULAR MEDICINE
- The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1
- (2008) Silvia Franchi et al. BMC IMMUNOLOGY
- Cytokine properties of prokineticins
- (2008) Justin Monnier et al. FEBS Journal
- Prokineticin-signaling pathway
- (2008) Elly S.W. Ngan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Enteric nervous system abnormalities in inflammatory bowel diseases
- (2008) v. villanacci et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cells
- (2007) Elly S.W. Ngan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search